th-302
Showing 1 - 15 of 15
Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Trial in Rockland, Darmstadt (TH-302, Gemcitabine, Placebo
Completed
- Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
- TH-302
- +2 more
-
Rockland, Massachusetts
- +1 more
Oct 26, 2017
Pancreatic Adenocarcinoma Trial in United States (Gemzar (Gemcitabine), TH-302)
Completed
- Pancreatic Adenocarcinoma
- Gemzar (Gemcitabine)
- TH-302
-
Birmingham, Alabama
- +58 more
Nov 20, 2017
Soft Tissue Sarcoma Trial (Th-302)
No longer available
- Soft Tissue Sarcoma
- Th-302
- (no location specified)
Oct 12, 2016
Solid Tumors Trial in Tucson, Yuma (TH-302)
Unknown status
- Solid Tumors
- TH-302
-
Tucson, Arizona
- +1 more
Jun 1, 2016
Multiple Myeloma Trial in United States (TH-302, TH-302 and Dexamethasone, TH-302 Dose Escalation and Dexamethasone in
Unknown status
- Multiple Myeloma
- TH-302
- +3 more
-
Monterey, California
- +9 more
Jun 1, 2016
Esophageal Cancer Trial (drug, other, radiation, procedure)
Withdrawn
- Esophageal Cancer
- TH-302
- +5 more
- (no location specified)
Apr 20, 2016
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Houston (TH-302)
Completed
- Acute Myelogenous Leukemia
- +5 more
- TH-302
-
Houston, TexasUniversity of Texas M.D. Anderson Cancer Center
May 5, 2015
NSCLC, Prostate Cancer, Pancreatic Cancer Trial in United States (TH-302)
Completed
- Non-Small Cell Lung Cancer
- +2 more
- TH-302
-
Scottsdale, Arizona
- +10 more
May 5, 2015
Advanced Renal Cell Carcinoma, Gastrointestinal Stromal Tumors, Pancreatic Neuroendocrine Tumors Trial in Goshen, Iowa City
Unknown status
- Advanced Renal Cell Carcinoma
- +2 more
- TH-302
-
Goshen, Indiana
- +1 more
Apr 18, 2014
Tumors, Hypoxia Trial in United States (TH-302)
Completed
- Tumors
- Hypoxia
- TH-302
-
Scottsdale, Arizona
- +6 more
Jul 25, 2012